 | • レポートコード：GIR201115199 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、幹細胞治療の世界市場を調査対象にし、幹細胞治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（自家、同種）、用途別分析（筋骨格系障害、傷・怪我、角膜、心血管疾患、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Osiris Therapeutics、Molmed、JCR Pharmaceutical、NuVasive、Anterogen、Chiesi Pharmaceuticals、Medi-post、Pharmicell、Takeda (TiGenix) ・企業別売上、市場シェア ・幹細胞治療の地域別市場分析 ・幹細胞治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・幹細胞治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・幹細胞治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・幹細胞治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・幹細胞治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・幹細胞治療の種類別市場規模2015-2020：自家、同種 ・幹細胞治療の用途別市場規模2015-2020：筋骨格系障害、傷・怪我、角膜、心血管疾患、その他 ・幹細胞治療の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The Stem Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Stem Cell Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 18.9%% in the forecast period of 2020 to 2025 and will expected to reach USD 828.7 million by 2025, from USD 415.3 million in 2019.
Market segmentation
Stem Cell Therapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Stem Cell Therapy market has been segmented into:
Autologous
Allogeneic
By Application, Stem Cell Therapy has been segmented into:
Musculoskeletal Disorder
Wounds & Injuries
Cornea
Cardiovascular Diseases
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Stem Cell Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Stem Cell Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Stem Cell Therapy market.
The report offers in-depth assessment of the growth and other aspects of the Stem Cell Therapy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Stem Cell Therapy Market Share Analysis
Stem Cell Therapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Stem Cell Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Stem Cell Therapy sales, revenue and market share for each player covered in this report.
The major players covered in Stem Cell Therapy are:
Osiris Therapeutics
Molmed
JCR Pharmaceutical
NuVasive
Anterogen
Chiesi Pharmaceuticals
Medi-post
Pharmicell
Takeda (TiGenix)
Among other players domestic and global, Stem Cell Therapy market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Stem Cell Therapy Market Overview
1.1 Product Overview and Scope of Stem Cell Therapy
1.2 Classification of Stem Cell Therapy by Type
1.2.1 Global Stem Cell Therapy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Stem Cell Therapy Revenue Market Share by Type in 2019
1.2.3 Autologous
1.2.4 Allogeneic
1.3 Global Stem Cell Therapy Market by Application
1.3.1 Overview: Global Stem Cell Therapy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Musculoskeletal Disorder
1.3.3 Wounds & Injuries
1.3.4 Cornea
1.3.5 Cardiovascular Diseases
1.3.6 Others
1.4 Global Stem Cell Therapy Market by Regions
1.4.1 Global Stem Cell Therapy Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Stem Cell Therapy (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Stem Cell Therapy Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Stem Cell Therapy Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Stem Cell Therapy Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Stem Cell Therapy Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Stem Cell Therapy Status and Prospect (2015-2025)
2 Company Profiles
2.1 Osiris Therapeutics
2.1.1 Osiris Therapeutics Details
2.1.2 Osiris Therapeutics Major Business
2.1.3 Osiris Therapeutics SWOT Analysis
2.1.4 Osiris Therapeutics Product and Services
2.1.5 Osiris Therapeutics Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 Molmed
2.2.1 Molmed Details
2.2.2 Molmed Major Business
2.2.3 Molmed SWOT Analysis
2.2.4 Molmed Product and Services
2.2.5 Molmed Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.3 JCR Pharmaceutical
2.3.1 JCR Pharmaceutical Details
2.3.2 JCR Pharmaceutical Major Business
2.3.3 JCR Pharmaceutical SWOT Analysis
2.3.4 JCR Pharmaceutical Product and Services
2.3.5 JCR Pharmaceutical Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.4 NuVasive
2.4.1 NuVasive Details
2.4.2 NuVasive Major Business
2.4.3 NuVasive SWOT Analysis
2.4.4 NuVasive Product and Services
2.4.5 NuVasive Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.5 Anterogen
2.5.1 Anterogen Details
2.5.2 Anterogen Major Business
2.5.3 Anterogen SWOT Analysis
2.5.4 Anterogen Product and Services
2.5.5 Anterogen Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.6 Chiesi Pharmaceuticals
2.6.1 Chiesi Pharmaceuticals Details
2.6.2 Chiesi Pharmaceuticals Major Business
2.6.3 Chiesi Pharmaceuticals Product and Services
2.6.4 Chiesi Pharmaceuticals Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.7 Medi-post
2.7.1 Medi-post Details
2.7.2 Medi-post Major Business
2.7.3 Medi-post Product and Services
2.7.4 Medi-post Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.8 Pharmicell
2.8.1 Pharmicell Details
2.8.2 Pharmicell Major Business
2.8.3 Pharmicell Product and Services
2.8.4 Pharmicell Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.9 Takeda (TiGenix)
2.9.1 Takeda (TiGenix) Details
2.9.2 Takeda (TiGenix) Major Business
2.9.3 Takeda (TiGenix) Product and Services
2.9.4 Takeda (TiGenix) Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Stem Cell Therapy Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Stem Cell Therapy Players Market Share
3.2.2 Top 10 Stem Cell Therapy Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Stem Cell Therapy Revenue and Market Share by Regions
4.2 North America Stem Cell Therapy Revenue and Growth Rate (2015-2020)
4.3 Europe Stem Cell Therapy Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Stem Cell Therapy Revenue and Growth Rate (2015-2020)
4.5 South America Stem Cell Therapy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Stem Cell Therapy Revenue and Growth Rate (2015-2020)
5 North America Stem Cell Therapy Revenue by Countries
5.1 North America Stem Cell Therapy Revenue by Countries (2015-2020)
5.2 USA Stem Cell Therapy Revenue and Growth Rate (2015-2020)
5.3 Canada Stem Cell Therapy Revenue and Growth Rate (2015-2020)
5.4 Mexico Stem Cell Therapy Revenue and Growth Rate (2015-2020)
6 Europe Stem Cell Therapy Revenue by Countries
6.1 Europe Stem Cell Therapy Revenue by Countries (2015-2020)
6.2 Germany Stem Cell Therapy Revenue and Growth Rate (2015-2020)
6.3 UK Stem Cell Therapy Revenue and Growth Rate (2015-2020)
6.4 France Stem Cell Therapy Revenue and Growth Rate (2015-2020)
6.5 Russia Stem Cell Therapy Revenue and Growth Rate (2015-2020)
6.6 Italy Stem Cell Therapy Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Stem Cell Therapy Revenue by Countries
7.1 Asia-Pacific Stem Cell Therapy Revenue by Countries (2015-2020)
7.2 China Stem Cell Therapy Revenue and Growth Rate (2015-2020)
7.3 Japan Stem Cell Therapy Revenue and Growth Rate (2015-2020)
7.4 Korea Stem Cell Therapy Revenue and Growth Rate (2015-2020)
7.5 India Stem Cell Therapy Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Stem Cell Therapy Revenue and Growth Rate (2015-2020)
8 South America Stem Cell Therapy Revenue by Countries
8.1 South America Stem Cell Therapy Revenue by Countries (2015-2020)
8.2 Brazil Stem Cell Therapy Revenue and Growth Rate (2015-2020)
8.3 Argentina Stem Cell Therapy Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Stem Cell Therapy by Countries
9.1 Middle East & Africa Stem Cell Therapy Revenue by Countries (2015-2020)
9.2 Saudi Arabia Stem Cell Therapy Revenue and Growth Rate (2015-2020)
9.3 UAE Stem Cell Therapy Revenue and Growth Rate (2015-2020)
9.4 Egypt Stem Cell Therapy Revenue and Growth Rate (2015-2020)
9.5 South Africa Stem Cell Therapy Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Stem Cell Therapy Revenue and Market Share by Type (2015-2020)
10.2 Global Stem Cell Therapy Market Forecast by Type (2019-2024)
10.3 Autologous Revenue Growth Rate (2015-2025)
10.4 Allogeneic Revenue Growth Rate (2015-2025)
11 Global Stem Cell Therapy Market Segment by Application
11.1 Global Stem Cell Therapy Revenue Market Share by Application (2015-2020)
11.2 Stem Cell Therapy Market Forecast by Application (2019-2024)
11.3 Musculoskeletal Disorder Revenue Growth (2015-2020)
11.4 Wounds & Injuries Revenue Growth (2015-2020)
11.5 Cornea Revenue Growth (2015-2020)
11.6 Cardiovascular Diseases Revenue Growth (2015-2020)
11.7 Others Revenue Growth (2015-2020)
12 Global Stem Cell Therapy Market Size Forecast (2021-2025)
12.1 Global Stem Cell Therapy Market Size Forecast (2021-2025)
12.2 Global Stem Cell Therapy Market Forecast by Regions (2021-2025)
12.3 North America Stem Cell Therapy Revenue Market Forecast (2021-2025)
12.4 Europe Stem Cell Therapy Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Stem Cell Therapy Revenue Market Forecast (2021-2025)
12.6 South America Stem Cell Therapy Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Stem Cell Therapy Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Stem Cell Therapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Stem Cell Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Stem Cell Therapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Stem Cell Therapy Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Stem Cell Therapy Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Osiris Therapeutics Corporate Information, Location and Competitors
Table 7. Osiris Therapeutics Stem Cell Therapy Major Business
Table 8. Osiris Therapeutics Stem Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 9. Osiris Therapeutics SWOT Analysis
Table 10. Osiris Therapeutics Stem Cell Therapy Product and Solutions
Table 11. Osiris Therapeutics Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Molmed Corporate Information, Location and Competitors
Table 13. Molmed Stem Cell Therapy Major Business
Table 14. Molmed Stem Cell Therapy Total Revenue (USD Million) (2018-2019)
Table 15. Molmed SWOT Analysis
Table 16. Molmed Stem Cell Therapy Product and Solutions
Table 17. Molmed Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. JCR Pharmaceutical Corporate Information, Location and Competitors
Table 19. JCR Pharmaceutical Stem Cell Therapy Major Business
Table 20. JCR Pharmaceutical Stem Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 21. JCR Pharmaceutical SWOT Analysis
Table 22. JCR Pharmaceutical Stem Cell Therapy Product and Solutions
Table 23. JCR Pharmaceutical Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. NuVasive Corporate Information, Location and Competitors
Table 25. NuVasive Stem Cell Therapy Major Business
Table 26. NuVasive Stem Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 27. NuVasive SWOT Analysis
Table 28. NuVasive Stem Cell Therapy Product and Solutions
Table 29. NuVasive Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Anterogen Corporate Information, Location and Competitors
Table 31. Anterogen Stem Cell Therapy Major Business
Table 32. Anterogen Stem Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 33. Anterogen SWOT Analysis
Table 34. Anterogen Stem Cell Therapy Product and Solutions
Table 35. Anterogen Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Chiesi Pharmaceuticals Corporate Information, Location and Competitors
Table 37. Chiesi Pharmaceuticals Stem Cell Therapy Major Business
Table 38. Chiesi Pharmaceuticals Stem Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 39. Chiesi Pharmaceuticals SWOT Analysis
Table 40. Chiesi Pharmaceuticals Stem Cell Therapy Product and Solutions
Table 41. Chiesi Pharmaceuticals Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Medi-post Corporate Information, Location and Competitors
Table 43. Medi-post Stem Cell Therapy Major Business
Table 44. Medi-post Stem Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 45. Medi-post SWOT Analysis
Table 46. Medi-post Stem Cell Therapy Product and Solutions
Table 47. Medi-post Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Pharmicell Corporate Information, Location and Competitors
Table 49. Pharmicell Stem Cell Therapy Major Business
Table 50. Pharmicell Stem Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 51. Pharmicell SWOT Analysis
Table 52. Pharmicell Stem Cell Therapy Product and Solutions
Table 53. Pharmicell Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Takeda (TiGenix) Corporate Information, Location and Competitors
Table 55. Takeda (TiGenix) Stem Cell Therapy Major Business
Table 56. Takeda (TiGenix) Stem Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 57. Takeda (TiGenix) SWOT Analysis
Table 58. Takeda (TiGenix) Stem Cell Therapy Product and Solutions
Table 59. Takeda (TiGenix) Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Global Stem Cell Therapy Revenue (Million USD) by Players (2015-2020)
Table 61. Global Stem Cell Therapy Revenue Share by Players (2015-2020)
Table 62. Global Stem Cell Therapy Revenue (Million USD) by Regions (2015-2020)
Table 63. Global Stem Cell Therapy Revenue Market Share by Regions (2015-2020)
Table 64. North America Stem Cell Therapy Revenue by Countries (2015-2020)
Table 65. North America Stem Cell Therapy Revenue Market Share by Countries (2015-2020)
Table 66. Europe Stem Cell Therapy Revenue (Million USD) by Countries (2015-2020)
Table 67. Asia-Pacific Stem Cell Therapy Revenue (Million USD) by Countries (2015-2020)
Table 68. South America Stem Cell Therapy Revenue by Countries (2015-2020)
Table 69. South America Stem Cell Therapy Revenue Market Share by Countries (2015-2020)
Table 70. Middle East and Africa Stem Cell Therapy Revenue (Million USD) by Countries (2015-2020)
Table 71. Middle East and Africa Stem Cell Therapy Revenue Market Share by Countries (2015-2020)
Table 72. Global Stem Cell Therapy Revenue (Million USD) by Type (2015-2020)
Table 73. Global Stem Cell Therapy Revenue Share by Type (2015-2020)
Table 74. Global Stem Cell Therapy Revenue Forecast by Type (2021-2025)
Table 75. Global Stem Cell Therapy Revenue by Application (2015-2020)
Table 76. Global Stem Cell Therapy Revenue Share by Application (2015-2020)
Table 77. Global Stem Cell Therapy Revenue Forecast by Application (2021-2025)
Table 78. Global Stem Cell Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Stem Cell Therapy Picture
Figure 2. Global Stem Cell Therapy Revenue Market Share by Type in 2019
Figure 3. Autologous Picture
Figure 4. Allogeneic Picture
Figure 5. Stem Cell Therapy Revenue Market Share by Application in 2019
Figure 6. Musculoskeletal Disorder Picture
Figure 7. Wounds & Injuries Picture
Figure 8. Cornea Picture
Figure 9. Cardiovascular Diseases Picture
Figure 10. Others Picture
Figure 11. Global Stem Cell Therapy Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Stem Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Stem Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Stem Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Stem Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Stem Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Stem Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Stem Cell Therapy Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Stem Cell Therapy Revenue Market Share in 2019
Figure 20. Global Top 10 Players Stem Cell Therapy Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Stem Cell Therapy Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Stem Cell Therapy Revenue Market Share by Regions (2015-2020)
Figure 24. Global Stem Cell Therapy Revenue Market Share by Regions in 2018
Figure 25. North America Stem Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 26. Europe Stem Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Stem Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 28. South America Stem Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Stem Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 30. North America Stem Cell Therapy Revenue Market Share by Countries (2015-2020)
Figure 31. North America Stem Cell Therapy Revenue Market Share by Countries in 2019
Figure 32. USA Stem Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 33. Canada Stem Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Stem Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 35. Europe Stem Cell Therapy Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Stem Cell Therapy Revenue Market Share by Countries in 2019
Figure 37. Germany Stem Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 38. UK Stem Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 39. France Stem Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 40. Russia Stem Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 41. Italy Stem Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Stem Cell Therapy Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Stem Cell Therapy Revenue Market Share by Countries in 2019
Figure 44. China Stem Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 45. Japan Stem Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 46. Korea Stem Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 47. India Stem Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Stem Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 49. South America Stem Cell Therapy Revenue Market Share by Countries (2015-2020)
Figure 50. South America Stem Cell Therapy Revenue Market Share by Countries in 2019
Figure 51. Brazil Stem Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Stem Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Stem Cell Therapy Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Stem Cell Therapy Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Stem Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 56. UAE Stem Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Stem Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Stem Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 59. Global Stem Cell Therapy Revenue Share by Type (2015-2020)
Figure 60. Global Stem Cell Therapy Revenue Share by Type in 2019
Figure 61. Global Stem Cell Therapy Market Share Forecast by Type (2021-2025)
Figure 62. Global Autologous Revenue Growth Rate (2015-2020)
Figure 63. Global Allogeneic Revenue Growth Rate (2015-2020)
Figure 64. Global Stem Cell Therapy Revenue Share by Application (2015-2020)
Figure 65. Global Stem Cell Therapy Revenue Share by Application in 2019
Figure 66. Global Stem Cell Therapy Market Share Forecast by Application (2021-2025)
Figure 67. Global Musculoskeletal Disorder Revenue Growth Rate (2015-2020)
Figure 68. Global Wounds & Injuries Revenue Growth Rate (2015-2020)
Figure 69. Global Cornea Revenue Growth Rate (2015-2020)
Figure 70. Global Cardiovascular Diseases Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Stem Cell Therapy Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Stem Cell Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Stem Cell Therapy Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Stem Cell Therapy Revenue Market Forecast (2021-2025)
Figure 76. Europe Stem Cell Therapy Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Stem Cell Therapy Revenue Market Forecast (2021-2025)
Figure 78. South America Stem Cell Therapy Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Stem Cell Therapy Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
筋骨格障害幹細胞療法の世界市場 2020年 Market Overview The global Musculoskeletal Disorder Stem Cell Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Mu…- 動物幹細胞療法の世界市場 2020年 Market Overview The Animal Stem Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…
- 細胞療法の世界市場 2020年 Market Overview The Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 細胞移植療法の世界市場 2020年 Market Overview The Cell Transplantatio Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- 細胞治療用細胞凍結培地の世界市場 2020年 Market Overview The global Cell Freezing Media for Cell Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 13.1% in the forecast period of 2020 to 2025 and will expected to reach USD 95 million by 2025, from USD 58 million in 2019. The Cell F…